CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes.

transcripts and mutations predict relapse in AML. High-risk transcripts are associated with distinct transcriptional landscapes and upregulation of early hematopoiesis genes.